Enwave Corporation Stock
€0.25
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | 6.960% | -3.361% | 9.524% | 59.722% | 66.667% | -20.553% | -68.707% |
| Resverlogix Corp | -9.730% | 4.630% | -15.672% | 88.333% | 109.259% | -31.928% | -90.504% |
| Aurinia Pharmaceuticals Inc. | -0.520% | -2.774% | -3.573% | 52.658% | 54.511% | 231.572% | 18.794% |
| Spectral Medical Inc | 1.920% | 1.299% | 1.299% | 145.283% | 143.750% | 219.672% | 214.516% |
News
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

